Accumulation of p62/<scp>SQSTM</scp>1 is associated with poor prognosis in patients with lung adenocarcinoma
Daisuke Inoue(The University of Osaka), Masayuki Yamamoto(Tohoku University), Hironobu Sasano(Tohoku University), Kennichi Satoh(Tohoku Medical and Pharmaceutical University), Mika Watanabe(Hokkaido University), Yoichiro Mitsuishi(Tohoku University), Yasuhiro Miki(Eli Lilly (Japan)), Takashi Suzuki(Tohoku University), Satoshi Suzuki, Hozumi Motohashi(Tohoku University), Shunichi Sugawara(Sendai Kousei Hospital), Akira Uruno(Tohoku University), Nobuyuki Tanaka(Waseda University), Takayuki Nakagawa(Wakayama Medical University), Hiroshi Kubo(Ritsumeikan University), Chiaki Endo(Tohoku University Hospital), Akira Sakurada(Tohoku University Hospital)
Cited by 205
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.7k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
|Nature Communications|2016|1.8k